You are in: EUROSPITAL / NEWS
05/07/2012 - Eurospital had recently launched Xeligen RT,

Eurospital had recently launched the most advance solution for the identification of HLA predisposition to develop Celiac Disease.

Xeligen RT is the only system in RT, which can determine genotypes characterizing the 5 risk classes predisposing to Celiac Disease. For more info please go to....e mettiamo il link

 

Eurospital Spa - Via Flavia 122 - 34147 Trieste - P.IVA: 00047510326 - C.S. € 2582000 CF e Reg. Impr. 00047510326 - REA TS 38955
Eurospital © 2018 - Privacy - Site credits